India Globalization Capital, Inc. (NYSE American: IGC) yesterday announced that during its 2016-2017 Annual Meeting of Shareholders on November 8, 2017, voting on Proposals Three and Four was adjourned to November 22, 2017 at 11:00 a.m. EST due to the lack of required stockholders needed. Stockholders of record on October 5, 2017 are eligible and requested by IGC to vote on these proposals that are available in the company’s proxy statement filed with the Securities and Exchange Commission (http://cnw.fm/J5mZZ). Eligible stockholders may vote at www.ProxyVote.com, by dialing 800-454-8683, or by returning a properly executed proxy card to InvestorCom. The following proposals were approved at the annual meeting: (1) the election of Sudhakar Shenoy and Ram Mukunda as directors, (2) the proposal to ratify AJSH & Company as the company’s independent registered public accounting firm for the 2018 fiscal year, (3) the adoption of the company’s 2018 Omnibus Incentive Plan, (4) a non-binding advisory resolution to approve the compensation of the company’s named executive officers, and (5) approval to adjourn the meeting.
To view the full press release, visit http://cnw.fm/1HtTp
About IGC
IGC is engaged in the development of cannabis based combination therapies to treat Alzheimer’s, pain, nausea, eating disorders, several end points of Parkinson’s, and epilepsy in dogs and cats. IGC has assembled a portfolio of patent filings and four lead product candidates addressing these conditions. The company is based in Maryland, USA. For more information please visit www.IGCinc.us.
More from CannabisNewsBreaks
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
For more information please visit https://www.cannabisnewswire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
